tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
Advertisement

VistaGen Therapeutics (VTGN) Technical Analysis

Compare
847 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
VistaGen Therapeutics’s (VTGN) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting VistaGen Therapeutics is a Buy.
VistaGen Therapeutics’s (VTGN) 20-Day exponential moving average is 2.75, while VistaGen Therapeutics’s (VTGN) share price is $2.73, making it a Sell.
VistaGen Therapeutics’s (VTGN) 50-Day exponential moving average is 2.56, while VistaGen Therapeutics’s (VTGN) share price is $2.73, making it a Buy.

VistaGen Therapeutics (VTGN) Pivot Points

Aug 08, 2025, 11:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.71
2.76
2.87
2.92
3.03
3.08
3.19
Fibonacci
2.76
2.82
2.86
2.92
2.98
3.02
3.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VistaGen Therapeutics (VTGN) Moving Averages

Aug 08, 2025, 11:30 AM
Period
Simple
Exponential
MA5
2.89Sell
2.87Sell
MA10
2.96Sell
2.86Sell
MA20
2.74Sell
2.75Sell
MA50
2.45Buy
2.56Buy
MA100
2.41Buy
2.52Buy
MA200
2.61Buy
2.67Buy
VistaGen Therapeutics’s (VTGN) 10-Day exponential moving average is 2.86, while VistaGen Therapeutics’s (VTGN) share price is $2.73, making it a Sell.
VistaGen Therapeutics’s (VTGN) 100-Day exponential moving average is 2.52, while VistaGen Therapeutics’s (VTGN) share price is $2.73, making it a Buy.
VistaGen Therapeutics’s (VTGN) stock price is $2.73 and VistaGen Therapeutics’s (VTGN) 50-day simple moving average is 2.45, creating a Buy signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.73 and VistaGen Therapeutics’s (VTGN) 100-day simple moving average is 2.41, creating a Buy signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.73 and VistaGen Therapeutics’s (VTGN) 200-day simple moving average is 2.61, creating a Buy signal.

VistaGen Therapeutics (VTGN) Technical Indicators

Aug 08, 2025, 11:30 AM
Name
Value
Implied Action
RSI (14)
52.13
Neutral
STOCH (9,6)
30.25
Neutral
STOCHRSI (14)
47.56
Neutral
MACD (12,26)
0.15
Buy
ADX (14)
33.48
Neutral
Williams %R
-72.29
Buy
CCI (14)
23.92
Neutral
ATR (14)
0.22
-
Ultimate Oscillator
49.55
Neutral
ROC
7.06
Buy
VistaGen Therapeutics’s (VTGN) Relative Strength Index (RSI) is 52.13, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Trend Strength Indicator (ADX) is 33.48, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Commodity Channel Index (CCI) is 23.92, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Price Rate of Change (ROC) is 7.06, creating a Buy signal.

FAQ

Is VTGN a Buy, Hold, or Sell?
Based on VTGN’s technical indicators, VTGN is a Buy.
    What is VTGN’s RSI (14)?
    VTGN’s RSI (14) is 52.13, which suggests VTGN is a Neutral.
      What is VTGN’s MACD?
      VTGN’s MACD is 0.15, which suggests VTGN is a Buy.
        What is VTGN’s 5-day moving average?
        VTGN’s 5-day moving average is 2.89, which suggests VTGN is a Sell.
          What is VTGN’s 20-day moving average?
          VTGN 20-day moving average is 2.73, which suggests VTGN is a Sell.
            What is VTGN’s 50-day moving average?
            VTGN’s 50-day moving average is 2.45, which suggests VTGN is a Buy.
              What is VTGN’s 200-day moving average?
              VTGN’s 200-day moving average is 2.61, which suggests VTGN is a Buy.
                What is VTGN’s Williams % R (14)?
                VTGN’s Williams % R (14) is -72.29, which suggests VTGN is a Buy.
                  What is VTGN’s CCI (14)?
                  VTGN’s CCI (14) is 23.92, which suggests VTGN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis